Pila Pharma AB (publ) (STO:PILA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.202
-0.126 (-9.49%)
Feb 11, 2026, 11:11 AM CET

Pila Pharma AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1.130.771.461.880.72
Other Revenue
-0.02---
1.130.791.461.880.72
Revenue Growth (YoY)
42.68%-46.01%-22.21%161.49%-
Cost of Revenue
6.956.693.33-0.04
Gross Profit
-5.82-5.9-1.871.880.68
Selling, General & Admin
11.133.4510.759.91
Other Operating Expenses
---00.01
Operating Expenses
2.082.214.5210.779.94
Operating Income
-7.89-8.11-6.39-8.89-9.26
Interest Expense
-0.22-0-0.04-0-0.03
Currency Exchange Gain (Loss)
--0.05---
Other Non Operating Income (Expenses)
-8.75-3.08-3.5-17.89-7.92
Pretax Income
-16.86-11.24-9.93-26.78-17.21
Net Income
-16.86-11.24-9.93-26.78-17.21
Net Income to Common
-16.86-11.24-9.93-26.78-17.21
Shares Outstanding (Basic)
3525211713
Shares Outstanding (Diluted)
3525211713
Shares Change (YoY)
35.92%20.66%22.29%31.86%30.89%
EPS (Basic)
-0.49-0.44-0.47-1.55-1.32
EPS (Diluted)
-0.62-0.44-0.47-1.55-1.32
Gross Margin
---127.74%100.00%94.68%
Operating Margin
-700.44%-1026.62%-436.99%-472.69%-1287.57%
Profit Margin
-1496.27%-1423.15%-678.73%-1423.73%-2392.46%
EBITDA
-6.82-7.03-5.32-8.87-9.24
D&A For EBITDA
1.081.081.080.020.02
EBIT
-7.89-8.11-6.39-8.89-9.26
Revenue as Reported
1.130.791.461.880.72
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.